abrdn Life Sciences Investors
HQL- Exchange
- NYSE
- SEC CIK
- 0000884121
No open-market purchases or sales by abrdn Life Sciences Investors insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $156.8M in total; no superinvestor holds it.
Holders of 5% or more of HQL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of abrdn Life Sciences Investors, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| First Trust Portfolios LP | 13G/A | 11.34%3.55M shares | +1.25 ppfrom 10.09% | Jan 21, 20216 filings | Oct 14, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
19 Schedule 13D and 13G filings on abrdn Life Sciences Investors, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Oct 14, 20269:42 AM ET | First Trust Portfolios LPand 2 others | 13G/A | 11.34%3.55M shares | +1.25 ppfrom 10.09% | Sep 30, 2026 | SEC |
| Mar 6, 202612:37 PM ET | First Trust Portfolios LPand 2 others | 13G/A | 10.09%3.02M shares | +3.76 ppfrom 6.33% | Feb 28, 2026 | SEC |
| Feb 23, 20265:50 PM ET | Saba Capital Management, L.P.and 2 others | 13D/A | 4.95%1.46M shares | −0.75 ppfrom 5.70%Below 5% | Feb 19, 2026 | SEC |
| Feb 11, 20266:53 PM ET | Saba Capital Management, L.P.and 2 others | 13D/A | 5.70%1.69M shares | −1.07 ppfrom 6.77% | Feb 9, 2026 | SEC |
| Jan 8, 20264:42 PM ET | Saba Capital Management, L.P.and 2 others | 13D/A | 6.77%2.00M shares | −1.11 ppfrom 7.88% | Jan 7, 2026 | SEC |
| Nov 24, 202511:36 AM ET | Saba Capital Management, L.P.and 2 others | 13D/A | 7.88%2.27M shares | −1.08 ppfrom 8.96% | Nov 21, 2025 | SEC |
| Sep 26, 20251:17 PM ET | Saba Capital Management, L.P.and 2 others | 13D/A | 8.96%2.59M shares | −1.37 ppfrom 10.33% | Sep 24, 2025 | SEC |
| Sep 3, 20254:58 PM ET | Saba Capital Management, L.P.and 2 others | 13D/A | 10.33%2.98M shares | −1.03 ppfrom 11.36% | Aug 29, 2025 | SEC |
| Apr 28, 20259:41 AM ET | First Trust Portfolios LPand 2 others | 13G | 6.33%1.83M shares | – | Mar 31, 2025 | SEC |
| Apr 1, 20259:49 PM ET | Saba Capital Management, L.P.and 2 others | 13D/A | 11.36%3.19M shares | – | Mar 31, 2025 | SEC |
| Jun 3, 2024 | Saba Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| Apr 29, 2024 | Saba Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| Apr 17, 2024 | Saba Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 7, 2024 | Saba Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| Jan 12, 2024 | Saba Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| Dec 29, 2023 | Saba Capital Management, L.P. | 13DOld format | – | New | – | SEC |
| Feb 6, 2023 | First Trust Portfolios LP | 13G/AOld format | – | – | – | SEC |
| Jan 21, 2022 | First Trust Portfolios LP | 13G/AOld format | – | – | – | SEC |
| Jan 21, 2021 | First Trust Portfolios LP | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell abrdn Life Sciences Investors shares.
No Form 144 notices for abrdn Life Sciences Investors are on file.